Search

Your search keyword '"Sekularac, N."' showing total 31 results

Search Constraints

Start Over You searched for: Author "Sekularac, N." Remove constraint Author: "Sekularac, N."
31 results on '"Sekularac, N."'

Search Results

3. Impact of diabetes on the management and outcomes in atrial fibrillation: an analysis from the ESC-EHRA EORP-AF Long-Term General Registry

4. Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry

6. Conditional source-term estimation evaluations for partially-premixed flames

7. Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry

8. Impact of renal impairment on atrial fibrillation

9. Epidemiology and impact of frailty in patients with atrial fibrillation in Europe

10. Impact of diabetes on the management and outcomes in atrial fibrillation: an analysis from the ESC-EHRA EORP-AF Long-Term General Registry

11. Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation:a report from ESC-EHRA EORP-AF Long-Term General Registry

12. Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry

13. Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

14. Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry

15. Cardiopoietic cell therapy for advanced ischemic heart failure : results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial

16. The Influence of Various Morphologic and Hemodynamic Carotid Plaque Characteristics on Neurological Events Onset and Deaths

17. The SAMe-TT2R2 score and quality of anticoagulation in atrial fibrillation:a simple aid to decision-making on who is suitable (or not) for vitamin K antagonists

18. Poster session IV * Friday 10 December 2010, 14:00-18:00

19. Progression of polyvascular disease--is there any rule?

20. Is there such thing as 'vaccine against aging'?

21. Design principles of media facade

25. The β-blocker uptitration in elderly with heart failure regarding biomarker levels: CIBIS-ELD substudy.

26. Should procalcitonin be measured routinely in acute decompensated heart failure?

27. Heart rate following short-term beta-blocker titration predicts all-cause mortality in elderly chronic heart failure patients: insights from the CIBIS-ELD trial.

28. Effect of beta blockade on natriuretic peptides and copeptin in elderly patients with heart failure and preserved or reduced ejection fraction: results from the CIBIS-ELD trial.

29. The influence of various morphologic and hemodynamic carotid plaque characteristics on neurological events onset and deaths.

30. Progression of polyvascular disease--is there any rule?

31. Is there such thing as "vaccine against aging"?

Catalog

Books, media, physical & digital resources